Figure 5.

Recommendations for the prevention, monitoring, and management of enfortumab vedotin-associated dermatologic events. ^aRecommendation based on clinical experience. ^bBased on clinical experience, a combination of moderate potency topical corticosteroids and topical antibiotics (eg, triamcinolone 0.1% cream and silver sulfadiazine 1% cream) can be used. Topical treatment is usually required for at least 4 weeks, and once the event has resolved or decreased by one grade of severity, it may be utilized on an as-needed basis.

Abbreviations: SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis.